[Drug Interaction between Sutent (sunitinib) and Bi-spirogyl (spiramycin-metronidazol): risk of toxicity]

Therapie. 2008 Nov-Dec;63(6):475-6.

[Article in French]

Authors

Sameh Trabelsi, Hammouda Boussen, Emna Gaïes, Issam Salouage, Sihem El Aïdli, Riadh Daghfous, Mohamed-Hedi Loueslati, Mohamed Lakhal, Chelbi Belkahia

PMID: 19374036

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Anti-Bacterial Agents / adverse effects*
Antineoplastic Agents / adverse effects*
Antineoplastic Agents / therapeutic use
Drug Interactions
Gastrointestinal Stromal Tumors / complications
Gastrointestinal Stromal Tumors / drug therapy
Humans
Indoles / adverse effects*
Indoles / therapeutic use
Male
Metronidazole / adverse effects*
Middle Aged
Pyrroles / adverse effects*
Pyrroles / therapeutic use
Spiramycin / adverse effects*
Sunitinib

Substances

Anti-Bacterial Agents
Antineoplastic Agents
Indoles
Pyrroles
Metronidazole
Spiramycin
Sunitinib